Potassium%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCl) is an essential electrolyte used to treat or prevent hypokalemia. It is available in oral and intravenous formulations. ## Primary Indications * Treatment and prevention of hypokalemia. ## Adult Dosing * **Oral:** * Prevention: 20 mEq (1.5 g KCl) per day in 1-2 divided doses. * Treatment: 40-100 mEq (3-7.5 g KCl) per day in 2-4 divided doses. Doses up to 200 mEq per day may be required in severe cases. * Maximum single dose: Typically 20 mEq (1.5 g) orally, especially with immediate-release formulations, to minimize GI irritation. Extended-release formulations may allow higher single doses as tolerated. * **Intravenous (IV):** * **General Replacement:** 20-40 mEq (1.5-3 g KCl) per day, added to a large volume of IV fluid. * **Severe Hypokalemia or Intractable Loss:** May require up to 200 mEq (15 g KCl) per 24 hours. * **Rate of Infusion:** * For peripheral IV: Do not exceed 10 mEq/hour (0.75 g KCl/hour). * For central IV: Rate can be increased up to 20 mEq/hour (1.5 g KCl/hour) or higher in life-threatening situations, *with continuous cardiac monitoring*. * **Maximum Concentration:** * Peripheral IV: 40 mEq/L (3 g KCl/L). * Central IV: 60 mEq/L (4.5 g KCl/L), though higher concentrations may be used cautiously in critical care settings with cardiac monitoring. ## Pediatric Dosing * Dosing is highly individualized based on serum potassium levels, clinical status, and age. * **Oral:** Typically 1-3 mEq/kg/day, divided into 2-4 doses. Maximum single dose usually 20 mEq (1.5 g) orally. * **Intravenous (IV):** * Average daily requirement: 1-2 mEq/kg/day. * Rate of infusion: Generally no faster than 0.5-1 mEq/kg/hour (up to 20 mEq/hour or 1.5 g/hour maximum in critical situations with cardiac monitoring). * Maximum concentration: Typically limited to 40 mEq/L (3 g KCl/L) for peripheral IV. ## Dose Adjustments * **Renal Impairment:** Use with extreme caution. Reduce dose significantly and monitor potassium levels closely. In severe renal impairment, potassium supplementation may be contraindicated. ## Contraindications * Hyperkalemia. * Conditions where oral KCl can be associated with obstruction or rupture of the GI tract (e.g., slow transit, esophageal compression, peptic ulcer disease, intestinal obstruction). ## Adverse Effects * **Common:** Nausea, vomiting, diarrhea, abdominal discomfort, flatulence. * **Serious:** Hyperkalemia (potentially life-threatening, characterized by muscle weakness, fatigue, paresthesias, cardiac arrhythmias, bradycardia, cardiac arrest), GI bleeding, ulceration, perforation, obstruction. ## Key Drug Interactions * **Potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene):** Increased risk of hyperkalemia. * **ACE inhibitors and ARBs:** Increased risk of hyperkalemia. * **NSAIDs:** Can reduce potassium excretion, increasing risk of hyperkalemia. * **Salt substitutes:** Often contain potassium chloride, increasing dietary potassium intake and risk of hyperkalemia. ## Monitoring * **Serum potassium levels:** Frequent monitoring is crucial, especially during IV administration, with dose changes, in patients with renal impairment, or those on interacting medications. * **Renal function (serum creatinine, BUN).** * **ECG:** Particularly if rapid IV infusion or concern for hyperkalemia. * **Signs and symptoms of hyperkalemia.** ## Clinical Pearls * Oral potassium chloride formulations can be irritating to the GI tract. Patients should be advised to take with food or fluids. Extended-release formulations may reduce GI irritation. * Dilute IV potassium chloride appropriately and administer with caution. Rapid IV administration can be fatal. * Always confirm the mEq to gram conversion (1 g KCl ≈ 13.4 mEq potassium). * Dosing in hypomagnesemic patients may require magnesium repletion first, as low magnesium can impair potassium repletion. *** *This information is intended for clinical use and is not a substitute for professional medical advice. Always consult the current prescribing information and relevant clinical guidelines for the most up-to-date and comprehensive details.*